SEARCH WITHIN CONTENT
VOLUME 24 , ISSUE S5 ( November, 2020 ) > List of Articles
Deven Juneja, Raymond D Savio, Shrikanth Srinivasan, Suresh Ramasubban, Pavan K Reddy, Manoj K Singh, Palepu BN Gopal, Dhruva Chaudhry, Deepak Govil, Subhal B Dixit
Keywords : Acute respiratory distress syndrome, Antibiotics, COVID-19, Critical care, SARS-CoV-2, Sepsis, Thromboprophylaxis, Venous thromboembolic
Citation Information :
License: CC BY-NC 4.0
Published Online: 18-11-2020
Copyright Statement: Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd.
In a resource-limited country like India, rationing of scarce critical care resources might be required to ensure appropriate delivery of care to the critically ill patients suffering from COVID-19 infection. Most of these patients require critical care support because of respiratory failure or presence of multiorgan dysfunction syndrome. As there is no pharmacological therapy available, respiratory support in the form of supplemental oxygen, noninvasive ventilation, and invasive mechanical ventilation remains mainstay of care in intensive care units. As there is still dearth of direct evidence, most of the data are extrapolated from the experience gained from the management of general critical care patients.
© Jaypee Brothers Medical Publishers (P) LTD.